» Articles » PMID: 11316791

The NF2 Tumor Suppressor Gene Product, Merlin, Mediates Contact Inhibition of Growth Through Interactions with CD44

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 2001 Apr 24
PMID 11316791
Citations 207
Authors
Affiliations
Soon will be listed here.
Abstract

The neurofibromatosis-2 (NF2) gene encodes merlin, an ezrin-radixin-moesin-(ERM)-related protein that functions as a tumor suppressor. We found that merlin mediates contact inhibition of growth through signals from the extracellular matrix. At high cell density, merlin becomes hypo-phosphorylated and inhibits cell growth in response to hyaluronate (HA), a mucopolysaccharide that surrounds cells. Merlin's growth-inhibitory activity depends on specific interaction with the cytoplasmic tail of CD44, a transmembrane HA receptor. At low cell density, merlin is phosphorylated, growth permissive, and exists in a complex with ezrin, moesin, and CD44. These data indicate that merlin and CD44 form a molecular switch that specifies cell growth arrest or proliferation.

Citing Articles

Current molecular understanding of central nervous system schwannomas.

Tsuchiya T, Miyawaki S, Teranishi Y, Ohara K, Hirano Y, Ogawa S Acta Neuropathol Commun. 2025; 13(1):24.

PMID: 39910685 PMC: 11796276. DOI: 10.1186/s40478-025-01937-w.


NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity.

Xu D, Yin S, Shu Y NPJ Precis Oncol. 2024; 8(1):133.

PMID: 38879686 PMC: 11180135. DOI: 10.1038/s41698-024-00627-5.


G6PD and ACSL3 are synthetic lethal partners of NF2 in Schwann cells.

Kyrkou A, Valla R, Zhang Y, Ambrosi G, Laier S, Muller-Decker K Nat Commun. 2024; 15(1):5115.

PMID: 38879607 PMC: 11180199. DOI: 10.1038/s41467-024-49298-7.


Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions.

Yuan R, Wang B, Wang Y, Liu P Oncol Ther. 2024; 12(2):257-276.

PMID: 38760612 PMC: 11187037. DOI: 10.1007/s40487-024-00279-2.


Evolving concepts in meningioma management in the era of genomics.

Hsieh A, Bi W, Ramesh V, Brastianos P, Plotkin S Cancer. 2024; 130(15):2586-2600.

PMID: 38753473 PMC: 11260245. DOI: 10.1002/cncr.35279.


References
1.
Wiederhold T, Herndon M, Gusella J, Ramesh V . Interdomain interaction of merlin isoforms and its influence on intermolecular binding to NHE-RF. J Biol Chem. 1999; 274(48):34438-42. DOI: 10.1074/jbc.274.48.34438. View

2.
Pearson M, Reczek D, BRETSCHER A, Karplus P . Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell. 2000; 101(3):259-70. DOI: 10.1016/s0092-8674(00)80836-3. View

3.
Giovannini M, van der Valk M, Niwa-Kawakita M, Abramowski V, Goutebroze L, Woodruff J . Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev. 2000; 14(13):1617-30. PMC: 316733. View

4.
Gautreau A, Louvard D, Arpin M . Morphogenic effects of ezrin require a phosphorylation-induced transition from oligomers to monomers at the plasma membrane. J Cell Biol. 2000; 150(1):193-203. PMC: 2185562. DOI: 10.1083/jcb.150.1.193. View

5.
Camenisch T, Spicer A, Brehm-Gibson T, Biesterfeldt J, Augustine M, Calabro Jr A . Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest. 2000; 106(3):349-60. PMC: 314332. DOI: 10.1172/JCI10272. View